U.S. Markets close in 3 hrs 18 mins

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
89.40+0.13 (+0.15%)
As of 12:41PM EDT. Market open.
Sign in to post a message.
  • p
    peachbacks
    Facebook has a group----Ozempic / Wegovy Weight Loss Support Group--- this shows the satisfaction and quality of life changes. A good provider will quickly pick up on this fact. The SSRI group is a major prescription arena and it provides quality of life. If this type of drug becomes p.o. , is covered by insurance and modifications of the drug improve efficiency just a bit, Wegovy and its offspring will have a market larger than the SSRI's, and may well be the most prescribed chronic drug group. I am confident that there are people at NVO working on 2.1 and 3.1.
    Bullish
  • p
    peachbacks
    Wegovy has 100 m potential customers in the USA. It may only reach a much smaller number because of cost. There is something in Economics called to Coase Theorem. Let's make things simple, the government is the buyer and NVO is the seller. The GOV wants the product at the lowest cost and for the most people. NVO wants profit and security. The product has XYZ cost to produce so profit is related to volume and units sold. There may be a golden spot for both sides to agree on to maximize each side's goals.
    The vaccine sales are interesting. PFE stock is not at a record and is just below its 2019 peak. I understand that the expense of developing the vaccine is from internal company pockets. The vaccine is way more valuable than what PFE is charging. What goes there? https://www.bloomberg.com/opinion/articles/2021-07-19/weight-loss-drug-wegovy-could-help-millions-will-insurers-buy-in?sref=X9N3NABa

    /
    The U.S. health system focuses on acute care and short-term costs at the expense of preventative treatment.
    The U.S. health system focuses on acute care and short-term costs at the expense of preventative treatment.
    www.bloomberg.com
    Bullish
  • L
    LostAllMyShirts
    Amazing a GREAT company yet zero people posting on here, like its a graveyard. WHY ?.
    Bullish
  • A
    Andrew1
    Any news on this 23% AH drop or yahoo error?
  • A
    Andy
    Disgusting that this company along with the other two that dominate the insulin market would inflate their prices to the point where many Americans have to ration their insulin. This isn’t right, and buying this makes you complicit in valuing profit over human life. When the US actually puts these companies in check, you better expect this stock to go soaring down. It’s not a matter of “if” but “when”.
    Bearish
  • L
    LostAllMyShirts
    That surely MUST have been a mistake by Yahoo ?. Checking the Danish Knoner listed Stock A shares shows 554.40 Kroner which is live NOW and equates to roughly 87.27 US$ so is correct on EU exchange.
    PHEW , if was mistake ,I was expecting to wake up to 25% loss. UNLESS someone offload mass of shares on NY exchange ?.
  • M
    Mike
    What Walmart has done with Novo is great news for all type one diabetics in USA especially those who dont have decent insurance etc. Too many where running out of insulin in the past due to rationing what they could afford to buy. I used to buy a vial of insulin for about $45.00 a vial back in the 90's but then greed or something else took over and did harm some people along the way... Novo and Walmart should win some very positive award for helping the least of least in this messed up World.
  • L
    LostAllMyShirts
    They keep deleting my Post. Look at Danish stock price today and is UP. I think must have been error.
    Bullish
  • H
    Harvey
    Elephant in the room:
    Why did NVO cut their retail Novolog prices at Walmart by over 50 % ?
    I assume it’s going to hurt their margins, even if Walmart sells it as a loss leader.
    Does NVO think that Lilly will not respond?
    To what end does this
    benefit NVO?
    Bullish
  • R
    Rayme
    The sema franchise with multiple indications will become a mega blockbuster by 2030 generating multibillions annually in sales with one molecule.
    Bullish
  • D
    David
    Big movement in the pre-market.
    Bullish
  • b
    blackoutbuzz
    NVO last split 2:1 back in Jan 2014 when the share price was ~90USD.
  • A
    Alexander
    Goal achieved, we hit $90. Expect some pullback short-term.
  • P
    Patti
    "Buy on rumor, sell on news" , is the stock market gospel !
  • a
    ahlbrandt
    I don’t know how I ever traded without using (http://Thetraderguide.com)! I look forward to their daily emails each morning that list pre-market movers based on thoroughly researched stock market and world news. I highly recommend anyone who invests in the stock market!
  • k
    kenneth
    So Walmart is now selling their insulin and they have the best weight loss Med on the market approved
  • p
    peachbacks
    Quality of life is the key to patient compliance. A 15% weight loss means a lot to many. There is a Facebook group and that is a tell. Mental health is an important factor in writing an RX - it is not just for longevity and that expands the clinical indications for Wegovy. Wegovy as an adjuvant for depression is a reasonable indication.
  • D
    DC
    as far as patent goes not that important this is a once a week injectable. will have daily pill out in 1 to 3 years. then profits soar. Remember NVO has 5 drugs they are selling based on the same molecule. This has never happened for any company in pharmaceutical history. All are still on patent.
  • R
    Rayme
    This stock will be over $90 by August. Dominating the Diabetes and Obesity markets.
    Bullish